JPS63301892A - Novel production of nonreducing end modified oligosaccharide derivative - Google Patents
Novel production of nonreducing end modified oligosaccharide derivativeInfo
- Publication number
- JPS63301892A JPS63301892A JP1049788A JP1049788A JPS63301892A JP S63301892 A JPS63301892 A JP S63301892A JP 1049788 A JP1049788 A JP 1049788A JP 1049788 A JP1049788 A JP 1049788A JP S63301892 A JPS63301892 A JP S63301892A
- Authority
- JP
- Japan
- Prior art keywords
- group
- substituted
- reducing
- cyclic
- tables
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001542 oligosaccharide Polymers 0.000 title claims abstract description 32
- 150000002482 oligosaccharides Chemical class 0.000 title claims abstract description 32
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- -1 (substituted)phenoxy group Chemical group 0.000 claims abstract description 22
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 18
- 239000008103 glucose Substances 0.000 claims abstract description 18
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims abstract description 14
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims abstract description 12
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 9
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 9
- 150000001299 aldehydes Chemical class 0.000 claims abstract description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 7
- 150000002576 ketones Chemical class 0.000 claims abstract description 7
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 6
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 claims abstract description 3
- PCKPVGOLPKLUHR-UHFFFAOYSA-N indoxyl Chemical group C1=CC=C2C(O)=CNC2=C1 PCKPVGOLPKLUHR-UHFFFAOYSA-N 0.000 claims abstract description 3
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 claims abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 12
- 125000001424 substituent group Chemical group 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 238000005917 acylation reaction Methods 0.000 claims description 4
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 4
- 125000003342 alkenyl group Chemical group 0.000 claims description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- 230000010933 acylation Effects 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 125000006165 cyclic alkyl group Chemical group 0.000 claims description 2
- 125000000542 sulfonic acid group Chemical group 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 22
- 108090000637 alpha-Amylases Proteins 0.000 abstract description 18
- 102000004139 alpha-Amylases Human genes 0.000 abstract description 18
- 229940024171 alpha-amylase Drugs 0.000 abstract description 18
- 239000000758 substrate Substances 0.000 abstract description 17
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 24
- 239000000243 solution Substances 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 23
- 238000000034 method Methods 0.000 description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000002904 solvent Substances 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 238000005259 measurement Methods 0.000 description 7
- 238000000691 measurement method Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 6
- 102000006995 beta-Glucosidase Human genes 0.000 description 5
- 108010047754 beta-Glucosidase Proteins 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000004382 Amylase Substances 0.000 description 4
- 102000013142 Amylases Human genes 0.000 description 4
- 108010065511 Amylases Proteins 0.000 description 4
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 4
- 229920002148 Gellan gum Polymers 0.000 description 4
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 4
- 102100022624 Glucoamylase Human genes 0.000 description 4
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 150000001241 acetals Chemical class 0.000 description 4
- 108010028144 alpha-Glucosidases Proteins 0.000 description 4
- 235000019418 amylase Nutrition 0.000 description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 125000003277 amino group Chemical class 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 150000004678 hydrides Chemical class 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YXGBAQKCCMQLGH-VQSBMGSQSA-N (2r,3r,4s,5s,6r)-2-[(2r,3s,4r,5r,6r)-6-[(2r,4r,5r,6r)-6-[(2r,3s,4r,5r,6r)-6-[(2r,3s,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dih Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](OC2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](OC=5C=CC(=CC=5)[N+]([O-])=O)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O YXGBAQKCCMQLGH-VQSBMGSQSA-N 0.000 description 2
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 2
- 108010056771 Glucosidases Proteins 0.000 description 2
- 102000004366 Glucosidases Human genes 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- NKDDWNXOKDWJAK-UHFFFAOYSA-N dimethoxymethane Chemical compound COCOC NKDDWNXOKDWJAK-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 150000003138 primary alcohols Chemical class 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- GJASCJZEBANVKX-CQZBUOJGSA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(2r,3r,4s,5r,6r)-6-(hydroxymethyl)-2-(4-nitrophenyl)-2,3-bis[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(phenylmethoxymethyl)oxan-2-yl]oxyoxan-4-yl]oxyoxa Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)(C=2C=CC(=CC=2)[N+]([O-])=O)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](COCC=2C=CC=CC=2)O1 GJASCJZEBANVKX-CQZBUOJGSA-N 0.000 description 1
- PDVFSPNIEOYOQL-UHFFFAOYSA-N (4-methylphenyl)sulfonyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OS(=O)(=O)C1=CC=C(C)C=C1 PDVFSPNIEOYOQL-UHFFFAOYSA-N 0.000 description 1
- XPIJMQVLTXAGME-UHFFFAOYSA-N 1,1-dimethoxycyclohexane Chemical compound COC1(OC)CCCCC1 XPIJMQVLTXAGME-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- PSGQCCSGKGJLRL-UHFFFAOYSA-N 4-methyl-2h-chromen-2-one Chemical group C1=CC=CC2=C1OC(=O)C=C2C PSGQCCSGKGJLRL-UHFFFAOYSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 101000935015 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) N-acetyl-6-hydroxytryptophan oxidase ivoB Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 102400000471 Isomaltase Human genes 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- 108020000290 Mannitol dehydrogenase Proteins 0.000 description 1
- 108010026867 Oligo-1,6-Glucosidase Proteins 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 101000650578 Salmonella phage P22 Regulatory protein C3 Proteins 0.000 description 1
- 101001040920 Triticum aestivum Alpha-amylase inhibitor 0.28 Proteins 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- FTNIPWXXIGNQQF-UHFFFAOYSA-N UNPD130147 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 description 1
- LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 description 1
- JFBZPFYRPYOZCQ-UHFFFAOYSA-N [Li].[Al] Chemical compound [Li].[Al] JFBZPFYRPYOZCQ-UHFFFAOYSA-N 0.000 description 1
- 125000004036 acetal group Chemical group 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 238000006359 acetalization reaction Methods 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- BNABBHGYYMZMOA-AHIHXIOASA-N alpha-maltoheptaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O[C@@H]6[C@H](O[C@H](O)[C@H](O)[C@H]6O)CO)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O BNABBHGYYMZMOA-AHIHXIOASA-N 0.000 description 1
- OCIBBXPLUVYKCH-QXVNYKTNSA-N alpha-maltohexaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O OCIBBXPLUVYKCH-QXVNYKTNSA-N 0.000 description 1
- LUEWUZLMQUOBSB-ZLBHSGTGSA-N alpha-maltotetraose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-ZLBHSGTGSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- YNKMHABLMGIIFX-UHFFFAOYSA-N benzaldehyde;methane Chemical compound C.O=CC1=CC=CC=C1 YNKMHABLMGIIFX-UHFFFAOYSA-N 0.000 description 1
- 108010019077 beta-Amylase Proteins 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- AOVXSQPLHCMTFC-UHFFFAOYSA-N butan-2-one;ethene Chemical group C=C.CCC(C)=O AOVXSQPLHCMTFC-UHFFFAOYSA-N 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000001719 carbohydrate derivatives Chemical class 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 230000020176 deacylation Effects 0.000 description 1
- 238000005947 deacylation reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011968 lewis acid catalyst Substances 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- DJMVHSOAUQHPSN-UHFFFAOYSA-N malto-hexaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(OC4C(C(O)C(O)C(CO)O4)O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 DJMVHSOAUQHPSN-UHFFFAOYSA-N 0.000 description 1
- FJCUPROCOFFUSR-UHFFFAOYSA-N malto-pentaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 FJCUPROCOFFUSR-UHFFFAOYSA-N 0.000 description 1
- UYQJCPNSAVWAFU-UHFFFAOYSA-N malto-tetraose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 UYQJCPNSAVWAFU-UHFFFAOYSA-N 0.000 description 1
- FJCUPROCOFFUSR-GMMZZHHDSA-N maltopentaose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 FJCUPROCOFFUSR-GMMZZHHDSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- RBXVOQPAMPBADW-UHFFFAOYSA-N nitrous acid;phenol Chemical class ON=O.OC1=CC=CC=C1 RBXVOQPAMPBADW-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 125000001174 sulfone group Chemical group 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N valeric aldehyde Natural products CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はα−アミラーゼ活性測定用基質として有用な非
還元末端修飾オリゴサツカライド誘導体の新規な製造法
に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a novel method for producing a non-reducing end-modified oligosaccharide derivative useful as a substrate for measuring α-amylase activity.
試料、特にヒト生体内の唾液、膵液、血液、尿中のα−
アミラーゼ活性の測定は医学上の診断において重要であ
る。例えば、膵炎、膵臓癌、耳下腺炎においては、血液
や尿中のα−アミラーゼ活性は通常の値に比べて著しい
上昇を示す。α- in samples, especially in human saliva, pancreatic juice, blood, and urine
Measuring amylase activity is important in medical diagnosis. For example, in pancreatitis, pancreatic cancer, and parotitis, α-amylase activity in blood and urine shows a marked increase compared to normal values.
α−アミラーゼ活性の測定方法については、これまで種
々の方法が発表されているが、大別すると、でんぷん、
アミロース、アミロペクチン等の長鎖の天然物及びその
修飾物を使用する方法と、グルコース残基数が4〜7個
のオリゴサッカライP及びその誘導体を使用する方法の
2種に分けられる。Various methods have been published for measuring α-amylase activity, but they can be roughly divided into starch, starch,
There are two types of methods: methods using long-chain natural products such as amylose and amylopectin and modified products thereof, and methods using oligosaccharide P having 4 to 7 glucose residues and its derivatives.
しかしながら、最近では、例えばマルトテトラオース、
マルトペンタオース、マルトヘキサオース、マルトヘプ
タオース等のオリゴサッカライrを基質に用いる方法(
特開昭50−56998号公報、特開昭53−3709
6号公報)やp−二トロフェノール等の色原体を還元末
端に結合したオリゴサッカライPを用いる方法(特開昭
54−51892号公報)等、均一で構造の明確な基質
を用いる方法が、これまで多(使用されてきたデンプン
を用いる方法に代わってアミラーゼ測定法の主流となり
つつある。However, recently, maltotetraose,
A method using oligosaccharides such as maltopentaose, maltohexaose, and maltoheptaose as a substrate (
JP-A-50-56998, JP-A-53-3709
6) and a method using a substrate with a uniform and clear structure, such as a method using oligosaccharide P with a chromogen such as p-nitrophenol bound to the reducing end (Japanese Patent Application Laid-Open No. 54-51892). However, the amylase measurement method is becoming the mainstream, replacing the method using starch that has been used extensively up until now.
これらの方法では通常、測定用共役酵素としてα−グル
コシダーゼ(E、C,3,2,1,20;(7−D−グ
ルコシドグルコヒPロラーゼ)又はグルコアミ5−ゼ(
E、C,3,2,1,3; 1.4−α−D−グルヵン
グルコヒPロラーゼ)、又はβ−グルコシダーゼ(E、
c。These methods usually use α-glucosidase (E, C, 3, 2, 1, 20; (7-D-glucoside glucohyplorase) or glucoamin 5-ase) as the coupled enzyme for measurement.
E, C, 3,2,1,3; 1.4-α-D-glucan glucosidase), or β-glucosidase (E,
c.
3.2.1.21;β−D−グルコシドグルコヒドロラ
ーゼ)を必要とする。3.2.1.21; β-D-glucoside glucohydrolase).
これらの共役酵素は、α−1,4−グルコシド結合を有
する糖鎖の非還元末端からα−1,4−グルコシド結合
を加水分解するエキソタイプの酵素であり、α−アミラ
ーゼ反応に関係なく基質を分解してしまう欠点を有する
。この為これら共役酵素を用いる上記測定法に於ては、
測定用試液が不安定で、試薬盲検値が極めて高くそれに
より測定精度を著しく悪(していた。さらに測定に充分
な量のグルコアミラーゼ、あるいはα−グルコシダーゼ
を使用できず、正確で且つ精度の高い測定法の組立が困
難であった。These conjugated enzymes are exotype enzymes that hydrolyze α-1,4-glucosidic bonds from the non-reducing end of sugar chains that have α-1,4-glucosidic bonds, and they are able to hydrolyze substrates regardless of the α-amylase reaction. It has the disadvantage that it decomposes. Therefore, in the above measurement method using these coupled enzymes,
The measurement reagent solution was unstable, and the reagent blind value was extremely high, which significantly degraded measurement accuracy.Furthermore, it was not possible to use a sufficient amount of glucoamylase or α-glucosidase for measurement, making it difficult to obtain accurate and precise measurements. It was difficult to assemble a measurement method with high
かかる問題点を解決すべく、本発明者らは、これまで数
種の新規な修飾オリゴサッカライPを合成し、これらを
用いるα−アミラーゼ活性の測定法について特許出願し
ている。In order to solve these problems, the present inventors have so far synthesized several types of novel modified oligosaccharide P, and have filed a patent application for a method for measuring α-amylase activity using these.
例えば、α−アミラーゼ活性を測定するに際し、グルコ
ースが4〜7個からなる直鎖状オリゴサッカライPの非
還元末端グルコースの6位の一級アルコール(−CH2
0H)が一般式−CF3Hで表わされる基で置換された
下記構造式を有するオリゴサツカライド誘導体を基質と
して使用するα−アミラーゼ活性の測定法がある(特開
昭59−51800号)。For example, when measuring α-amylase activity, the primary alcohol (-CH2
There is a method for measuring α-amylase activity using as a substrate an oligosaccharide derivative having the following structural formula in which 0H) is substituted with a group represented by the general formula -CF3H (Japanese Patent Laid-Open No. 59-51800).
(式中、右端のグルコース単位は還元性基、kは2〜5
の整数であり、Rは、例えばピリジルアミノ基を表わす
。)
これらの基質は、均一で構造が明確でありα−グルコシ
ダーゼ、β−グルコシダーゼ又はグルコアミラーゼの基
質とならない点に特徴を有している。しかしながら、こ
れらの基質を用いてα−アミラーゼ活性を測定するには
、高速液体クロマトグラフィー法によるか、或いはα−
グルコシダーゼ、β−グルコシダーゼ又はグルコアミラ
ーゼを共役酵素に用いて生成するグルコースを測定する
方法によらねばならず、前者は特殊な機器を必要とする
点、後者は検体中に含まれるグルコースにより影響を受
ける点等に問題があった。(In the formula, the rightmost glucose unit is a reducing group, k is 2 to 5
is an integer, and R represents, for example, a pyridylamino group. ) These substrates are characterized in that they are uniform and have a clear structure, and do not serve as substrates for α-glucosidase, β-glucosidase, or glucoamylase. However, in order to measure α-amylase activity using these substrates, it is necessary to use high-performance liquid chromatography or α-amylase activity.
A method must be used to measure glucose produced using glucosidase, β-glucosidase, or glucoamylase as a coupled enzyme; the former requires special equipment, and the latter is affected by the glucose contained in the sample. There was a problem with points etc.
そこで、本発明者らは更に研究を重ね、このような問題
を有さないα−アミラーゼ活性測定法を見出し、これを
特許出願している(特開昭61−83195号)。Therefore, the present inventors conducted further research and found a method for measuring α-amylase activity that does not have such problems, and has filed a patent application for this method (Japanese Patent Application Laid-Open No. 83195/1983).
即ち、グルコースが4〜7個からなる直鎖状オリゴサツ
カライドの非還元末端グルコースの6位の一級アルコー
ル(−CH20H)が−CH2Roで示される基で置換
され、更に、還元末端グルコースの1位が7エノキシ基
若しくは置換フェノキシ基又はウンベリフェリル基で置
換された、下記構造式〔A〕、を表わす(但し、〜〜穐
は水素、低級アルキル基、低級アルコキシ基、ニトロ
基、カルゼキシル基、スルホン基又は)・ロゲンを表わ
し、夫々同じでありても異なっていても良く、も は水
素、低級アルコキシ基、ノ・ロゲン又はニトロ基を表わ
すまた、−は水素又はメチル基を表わす。)。〕で示さ
れるオリがサツカライド誘導体を基質として用いるα−
アミラーゼ活性測定法がそれである。That is, the primary alcohol (-CH20H) at the 6th position of the non-reducing terminal glucose of a linear oligosaccharide consisting of 4 to 7 glucose atoms is substituted with a group represented by -CH2Ro, and the 1st-position of the reducing terminal glucose is substituted with a group represented by -CH2Ro. represents the following structural formula [A], in which is substituted with a 7-enoxy group, a substituted phenoxy group, or an umbelliferyl group (where 〜〜马 is hydrogen, a lower alkyl group, a lower alkoxy group, a nitro group, a carzexyl group, It represents a sulfone group or a rogen, which may be the same or different, and each represents hydrogen, a lower alkoxy group, a rogen or a nitro group, and - represents hydrogen or a methyl group. ). ] is the α-
This is the amylase activity measurement method.
この測定法は従来のα−アミラーゼ活性測定法が有する
種々の問題点を全て解決した優れた測定法であるが、用
いる基質の合成収率がいずれも非常に低いという点で実
用化(企業化)に際し問題が残る。従って、α−アミラ
ーゼ活性測定用の優れた基質となり得る非還元末端修飾
オリゴ9サツカライド誘導体をより収率よく得ることが
できる新規で効果的な製造法の出現が待ち望まれている
現状にある。Although this measurement method is an excellent measurement method that solves all the problems of the conventional α-amylase activity measurement method, it has not been put into practical use (commercialization) because the synthesis yield of the substrates used is very low. ), a problem remains. Therefore, the emergence of a new and effective production method that can obtain non-reducing end-modified oligo-9 saccharide derivatives with higher yields that can serve as excellent substrates for measuring α-amylase activity is currently being awaited.
本発明は上記した如き状況に鑑みなされたもので、α−
アミラーゼ活性測定用基質として有用な非還元末端修飾
オリコ゛サッカライP誘導体が容易に且つ収率よく得ら
れる製造方法を提供することを目的とする。The present invention was made in view of the above-mentioned situation, and
The object of the present invention is to provide a manufacturing method that allows easy and high-yield production of non-reducing end-modified oligosaccharide P derivatives useful as substrates for measuring amylase activity.
本発明は、還元末端グルコースの1位水酸基が置換基を
有していても良いフェノキシ基、置換基を有していても
良いナフトキシ基、置換基を有していても良いウンベリ
フェリル基、置換基を有していても良いインドキシル基
又はフルクトース残基で置換された修飾オリゴサツカラ
イドの非還元末端グルコースにアルデヒド類、ケトン類
、アセタール類又はケタール類を反応させて4.6−0
−環状アセタール又は4.6−0−環状ケタールとし、
次いでこれを還元することを特徴とする、一般式[1]
〔式中、R1はベンジル基、置換ベンジル基(置換基は
、低級アルキル基、低級アルコキシ基、アルキル置換ア
ミノ基、カルゼキシル基、ニトロ基又はハロゲン原子を
示す。)、2−.3−又は4−ピリジルメチル基、炭素
数1〜6の直鎖状、分枝状又は環状のアルキル基又は炭
素数1〜6のアルケニル基を表わし、R2は
(但し、R3−R6は水素原子、低級アルキル基、低級
アルコキシ基、ニトロ基、カルゼキシル基、スルホン酸
基又はノ・ロゲン原子を表わし、夫々同じであっても異
なっていても良く、また、RとR又はR4とR6とが結
合して芳香環を形成していても良い。R7は水素原子、
低級アルコキシ基、ノ10ゲン原子又はニトロ基を表わ
す。また、Rは水素原子、メチル基又はトリフルオロメ
チル基を表わし、R9は水素原子又はノ10ゲン原子を
表わす。)又はH
を表わし、nは2〜5の整数を表わす。〕で示されるオ
リゴサツカライド誘導体の製造法である。The present invention provides a phenoxy group which may have a substituent at the 1-position hydroxyl group of the reducing end glucose, a naphthoxy group which may have a substituent, an umbelliferyl group which may have a substituent, 4.6-0 by reacting aldehydes, ketones, acetals or ketals with the non-reducing terminal glucose of a modified oligosaccharide substituted with an indoxyl group or fructose residue which may have a substituent.
- a cyclic acetal or a 4.6-0-cyclic ketal;
This is then reduced to form a compound of the general formula [1] [wherein R1 is a benzyl group, a substituted benzyl group (the substituent is a lower alkyl group, a lower alkoxy group, an alkyl-substituted amino group, a carzexyl group, a nitro represents a group or a halogen atom), 2-. It represents a 3- or 4-pyridylmethyl group, a linear, branched or cyclic alkyl group having 1 to 6 carbon atoms, or an alkenyl group having 1 to 6 carbon atoms, and R2 is (however, R3-R6 are hydrogen atoms , represents a lower alkyl group, a lower alkoxy group, a nitro group, a carxyl group, a sulfonic acid group, or a norogen atom, and each may be the same or different, and R and R or R4 and R6 are bonded. to form an aromatic ring.R7 is a hydrogen atom,
Represents a lower alkoxy group, a nitrogen atom or a nitro group. Further, R represents a hydrogen atom, a methyl group or a trifluoromethyl group, and R9 represents a hydrogen atom or a hydrogen atom. ) or H, and n represents an integer of 2 to 5. ] This is a method for producing an oligosaccharide derivative.
本発明の製造法は、還元末端グルコースの1位水酸基が
上記R2で示される基で置換された、a〕で示される還
元末端修飾オリゴサツカライド誘導体を原料として、通
常下記の如くして行われる。The production method of the present invention is usually carried out as follows using as a raw material the reducing end-modified oligosaccharide derivative represented by a] in which the 1-position hydroxyl group of the reducing end glucose is substituted with the group represented by R2 above. .
即ち、先ず、式CIIIで示されるオリゴサツカライド
誘導体にアルデヒド類、ケトン類、アセタール類又はケ
タール類を作用させて非還元末端グルコースの4位と6
位との間に環状アセタール基を形成させる。式〔■〕で
示されるオリゴサツカライド誘導体は、市販品をそのま
ま用いてもよ〜・し、例えば特開昭54−51892号
公報等に記載の方法に準じてこれを合成しても良い。ま
た、反応に用いるアルデヒド類としては、例えば、ベン
ズアルデヒド、トリルアルデヒド等の芳香族アルデヒド
類、アセトアルデヒド、プロビオンアルデヒP。That is, first, an aldehyde, a ketone, an acetal, or a ketal is reacted on the oligosaccharide derivative represented by the formula CIII to convert the 4- and 6-positions of the non-reducing terminal glucose.
A cyclic acetal group is formed between the two positions. As the oligosaccharide derivative represented by the formula [■], a commercially available product may be used as it is, or it may be synthesized, for example, according to the method described in JP-A-54-51892. Examples of aldehydes used in the reaction include aromatic aldehydes such as benzaldehyde and tolylaldehyde, acetaldehyde, and probionaldehyde P.
ブチルアルデヒド等の脂肪族アルデヒド類等が挙げられ
、ケトン類としては、例えば、アセトン。Examples include aliphatic aldehydes such as butyraldehyde, and examples of ketones include acetone.
メチルエチルケト/等が挙げられ、アセタール類として
は、例えば、メチラール、ペンズアルデヒPジメチルア
セタール、アセトアルデヒドジエチルアセタール、アセ
トアルデヒドジエチルアセタール等が挙げられ、ケター
ル類としては、例え&f。Examples of the acetals include methylal, penzaldehy P dimethyl acetal, acetaldehyde diethyl acetal, and acetaldehyde diethyl acetal. Examples of the ketals include &f.
メチルエチルケトンエチレンケタール、シクロヘキサノ
ンジメチルケタール等が挙げられるが、これらに限定さ
れるものではなく、式[11]で示されるオリゴサツカ
ライド誘導体の非還元末端グルコースの4,6位を環状
アセタール化又は環状ケタール化し得るアルデヒド類、
ケトン類、アセタール類又はケタール類であればいずれ
にても良〜・。使用モル比は通常、オリゴサツカライド
誘導体に対し1〜100倍モル程度である。反応は通常
、p−トルエンスルホン酸、塩化亜鉛等のルイス酸触媒
の存在下、例えば、ジメチルホルムアミド(DMF)等
適当な溶媒中で行われ、反応温度は通常、室温乃至還流
温度、反応時間は、反応温度により若干具なるが、通常
0.5〜12時間程度である。Examples include, but are not limited to, methyl ethyl ketone ethylene ketal, cyclohexanone dimethyl ketal, etc., and cyclic acetalization or cyclic ketal formation at the 4 and 6 positions of the non-reducing terminal glucose of the oligosaccharide derivative represented by formula [11] aldehydes that can be converted into
Any ketones, acetals, or ketals are fine. The molar ratio used is usually about 1 to 100 times the molar amount of the oligosaccharide derivative. The reaction is usually carried out in the presence of a Lewis acid catalyst such as p-toluenesulfonic acid or zinc chloride in a suitable solvent such as dimethylformamide (DMF), and the reaction temperature is usually room temperature to reflux temperature, and the reaction time is Although the time depends on the reaction temperature, it is usually about 0.5 to 12 hours.
かくして得られた環状アセタール化物は、通常、アシル
化により、他の水酸基を修飾した後、還元工程に付され
る。The cyclic acetal product thus obtained is usually subjected to a reduction step after modifying other hydroxyl groups by acylation.
アシル化反応は、例えば、ピリジン等の塩基の存在下ア
シル化剤として無水酢酸、アセチルクロリド、ベンゾイ
ルクロリド等を用い、常法に従ってこれを行えば足りる
。The acylation reaction may be carried out in the presence of a base such as pyridine using acetic anhydride, acetyl chloride, benzoyl chloride, or the like as an acylating agent according to a conventional method.
アシル化反応は必須ではないが、次工程(還元工程)の
反応溶媒に対する溶解性を高める意味で好ましい。Although the acylation reaction is not essential, it is preferred in the sense of increasing solubility in the reaction solvent of the next step (reduction step).
還元工程は、通常、還元剤としてす) IJウムシアノ
ゼロハイドライド、ナトリウムゼロハイドライド、リチ
ウムアルミニラムノ・イPライド、ピリノンゼラン、−
)メチルアミンゼラン、トリメチルアミンぎラン、 t
art−ブチルアミンぎラン、ジボラン等を用い、塩化
アルミニウム、三弗化ホウ素、。The reduction process is usually carried out as a reducing agent) IJ umcyano zero hydride, sodium zero hydride, lithium aluminum ramino hydride, pyrinone gelane, -
) Methylamine gellan, trimethylamine gelan, t
Using art-butylamine, diborane, aluminum chloride, boron trifluoride, etc.
塩化亜鉛、p−)ルエンスルホン酸、メタンスルホン酸
、塩化水素ガス等の酸触媒の存在下、適当な溶媒(例え
ば、テトラヒドロフラン(THF) 等)中、通常、0
〜50℃で、数十分乃至数時間反応させることにより行
われる。還元剤の使用量は通常、オリゴサツカライド誘
導体に対し1〜1000倍モル、また酸触媒の使用量は
還元剤に対し、通常、0.5〜5モル程度である。Usually, 0
The reaction is carried out at ~50°C for several tens of minutes to several hours. The amount of the reducing agent used is usually 1 to 1000 times the mole of the oligosaccharide derivative, and the amount of the acid catalyst used is usually about 0.5 to 5 moles relative to the reducing agent.
アシル保護しである場合は、還元後、常法により、例え
ば、0.01〜1.ONナトリウムメチラート・メタノ
ール溶液等で数時間乃至数十時間室温乃至若干加温下処
理する等して脱アシル化すれば、目的とする非還元末端
修飾オリゴサツカライド誘導体が容易に得られる。各工
程に於ける反応後の後処理等は常法に従ってこれを行え
ばよ(、また、最終生成物の精製もカラムクロマトグラ
フィー等常法に従ってこれを行えば足りる。In the case of acyl protection, after reduction, for example, 0.01 to 1. The desired non-reducing end-modified oligosaccharide derivative can be easily obtained by deacylation by treating with ON sodium methylate/methanol solution for several hours to several tens of hours at room temperature or with slight heating. Post-treatments after the reaction in each step can be carried out according to conventional methods (and purification of the final product can also be carried out according to conventional methods such as column chromatography.
オリゴサッカライPのα−1,4結合は、酸性条件下で
は酸水解され、また、無水メタノール−I(Ct条件で
はメタツリシスされることから、或は、酸性条件下での
配糖体結合(還元末端グルコースとR2で示される基と
の結合)の安定性が不明であることから、式〔「〕で示
される如きオリゴサツカライド誘導体から導かれるオリ
ゴサツカライド誘導体がこのような還元処理に耐え得る
か否かはこれまで全(不明であったが、意外にも上記還
元処理により伺の不都合もな(環状アセタール部を開環
させることができることを本発明者らが初めて見出し、
本発明を完成するに到った。The α-1,4 bond of oligosaccharide P is hydrolyzed by acid under acidic conditions, and is metathulysed under conditions of anhydrous methanol-I (Ct). Since the stability of the bond between the reducing terminal glucose and the group represented by R2 is unknown, it is possible that the oligosaccharide derivative derived from the oligosaccharide derivative represented by the formula [] will withstand such reduction treatment. Until now, it was unclear whether or not the cyclic acetal moiety could be obtained, but surprisingly, the present inventors discovered for the first time that it was possible to open the cyclic acetal moiety without any inconvenience.
The present invention has now been completed.
本発明の方法により製造可能な一般式C1)で示される
オリゴサツカライド誘導体に於て、非還元末端グルコー
スの6位の−CH20R1のR1としてはベンジル基、
置換ベンジル基(置換基としては、例えばメチル基、エ
チル基、プロピル基、ブチル基等の低級アルキル基、例
えばメトキシ基、エトキシ基、プロポキシ基、ブトキシ
基等の低級アルコキシ基、例えばジメチルアミノ基、ジ
エチルアミ/基、N−エチル−N−(β−ヒPロキシエ
チル)アミン基等の置換アミノ基、カルゼキシル基、ニ
トロ基又は、例えば塩素、臭素、沃素等のハロゲン原子
等が挙げられる。)、2−23−又は4−ピリジルメチ
ル基、例えばメチル基、エチル基。In the oligosaccharide derivative represented by the general formula C1) that can be produced by the method of the present invention, R1 of -CH20R1 at the 6-position of the non-reducing terminal glucose is a benzyl group,
Substituted benzyl group (substituents include, for example, lower alkyl groups such as methyl, ethyl, propyl, and butyl; lower alkoxy groups such as methoxy, ethoxy, propoxy, and butoxy; for example, dimethylamino group; Substituted amino groups such as diethylamine/group, N-ethyl-N-(β-hyproxethyl)amine group, carxyl group, nitro group, or halogen atoms such as chlorine, bromine, and iodine, etc.), 2 -23- or 4-pyridylmethyl group, such as methyl group, ethyl group.
1so−プロピル基、n−ブチル基、 tert−ブチ
ル基、n−ペンチル基、 1so−アミル基、n−ヘキ
シル基、シクロペンチル基、シクロヘキシル基環炭素数
1〜6の直鎖状1分校状又は環状のアルキル基、例エバ
エチニル基、2−プロベニ、+1412一ブテニル基等
炭素数1〜6のアルケニル基等が挙げられる。また、一
般式[1)の還元末端グルコ良いフェノキシ基又は、置
換基を有していても良いナフトキシ基としては、オリが
糖の還元末端に結合し、グルコアミラーゼ(E、C,3
,2,1,3,)、α−グルコシダーゼ[:E、C,3
,2,1,20,]、]β−グルコシダーゼ:E、C,
3,2,1,21,]、イソマルターゼ(E、c、3.
z、t、1o、]又は]β−アミラーゼE、C,3,2
,1,2,:1等の共役酵素の作用を受けて加水分解さ
れ得るものであり、更に、氷解後は、ニトロフェノール
類の如くそれ自体可視部に吸収を有するものか、又はカ
テコールオキシダーゼ、ラッカーゼ、チロシナーゼ又は
モノフェノールオキシダーゼ等の酸化酵素の作用を受け
てカプラーとカップリングして色素を生ずるか、或は酸
化剤によりカプラーとカップリングして色素を生ずるも
のであればいずれにても良い。このような条件を満足す
るR2の具体例としては、例えば、り−二)ロフェノキ
シ基、m−ニトロフェノキシ基、0−クロロフェノキシ
基、p−クロロフェノキシ基、2,6−ジクロロフェノ
キシ基、2−クロロ−4−二トロフェノキシ基、0−メ
トキシフェノキシ基、p−メトキシフェノキシ基、0−
メチルフェノキシ基、0−カルゼキシフェノキシ基、0
−スルホフェノキシ基、1−ナフトキシ基、2−スルホ
−1−ナフトキシ基、2−カルゼキシー1−ナフトキシ
基等が挙げられるが、これらに限定されない。1so-propyl group, n-butyl group, tert-butyl group, n-pentyl group, 1so-amyl group, n-hexyl group, cyclopentyl group, cyclohexyl group Straight chain monobranched or cyclic having 1 to 6 ring carbon atoms Examples include alkenyl groups having 1 to 6 carbon atoms such as evaethynyl group, 2-probenyl group, and +1412-1-butenyl group. In addition, the phenoxy group or naphthoxy group which may have a substituent in the general formula [1] has a good reducing terminal glucolysis, and the ori is bonded to the reducing terminal of the sugar, and glucoamylase (E, C, 3
, 2, 1, 3,), α-glucosidase [:E, C, 3
, 2, 1, 20, ], ] β-glucosidase: E, C,
3,2,1,21,], isomaltase (E, c, 3.
z, t, 1o,] or] β-amylase E, C, 3,2
, 1, 2,: 1, etc., and after thawing the ice, it can be hydrolyzed by the action of conjugated enzymes such as nitrophenols, or catechol oxidase, Any substance that produces a dye by coupling with a coupler under the action of an oxidizing enzyme such as laccase, tyrosinase or monophenol oxidase, or which produces a dye by coupling with a coupler with an oxidizing agent may be used. . Specific examples of R2 satisfying such conditions include, for example, ri-di)lophenoxy group, m-nitrophenoxy group, 0-chlorophenoxy group, p-chlorophenoxy group, 2,6-dichlorophenoxy group, 2-chloro-4-nitrophenoxy group, 0-methoxyphenoxy group, p-methoxyphenoxy group, 0-
Methylphenoxy group, 0-calcexyphenoxy group, 0
Examples include, but are not limited to, -sulfophenoxy group, 1-naphthoxy group, 2-sulfo-1-naphthoxy group, 2-calzexy-1-naphthoxy group, and the like.
していてもよいウンベリフェリル基の具体例としては、
R8が水素原子のウンベリフェリル基又はR8がメチル
基の4−メチルウンベリフェリル基又はR8がトリフル
オロメチル基の4−トリフルオロメしていても良いイン
−キシル基の具体例としては、例えば、イン−キシル基
、5−ブロモインドキシの場合は共役酵素による氷解後
、マンニトールデヒドロゲナーゼとNADHを作用させ
たときに生ずるNADHの減少の度合を測定することに
よりアミラ一本発明の製造法によれば、α−アミラーゼ
活性測定用基質として、或はヒトα−アミラーゼの各ア
イソデイム活性の分別測定用基質として有用な非還元末
端修飾オリゴサツカライドを簡単な反応操作で、収率よ
く得ることができる。Specific examples of the umbelliferyl group that may be
Specific examples of the umbelliferyl group where R8 is a hydrogen atom, the 4-methylumbelliferyl group where R8 is a methyl group, or the in-xyl group which may be 4-trifluoromethane where R8 is a trifluoromethyl group include, for example. , in-xyl group, and 5-bromoindoxy, after deicing with a conjugated enzyme, the degree of decrease in NADH caused by the action of mannitol dehydrogenase and NADH was measured. For example, a non-reducing end-modified oligosaccharide useful as a substrate for measuring α-amylase activity or as a substrate for differentially measuring the activity of each isodeme of human α-amylase can be obtained in good yield by simple reaction operations. .
以下に実施例を示すが本発明はこれら実施例により何ら
限定されるものではない。Examples are shown below, but the present invention is not limited to these Examples in any way.
実施例1. p−ニトロフェニル 0−(6−0−ベ
ンジル)−α−D−グルコピラインルー(1→4)−〇
−α−D−グルコピラノシルー(1→4)−〇−α−D
−グルコピラノシルー(1→4)−〇−α−D−グルコ
ピラノシルー(1→4)−α−−D−グルコピラノシP
(以下、BG5Pと略す。)の合成
p−ニトロフェニル−α−D−マルトペンタオシド32
をDMF 50 dに溶解後、ペンズアルデヒrジメチ
ルアセタール15m/、p−トルエンスルホン酸(無水
)14を加え、50℃で3時間攪拌反応させた。反応後
、ピリジン100mA’を加え水冷下、ペンゾイルクロ
リ)’ 60 mA’を滴下して反応させ、反応液を2
00 trtlの飽和垂炭酸水素ナトリウム溶液にあけ
て反応を停止させた。クロロホルム200dで抽出し飽
和食塩水で2回洗浄後、溶媒を留去した。得られたシロ
ップを114頚コルベンに移し、THF 250 tn
lに溶解後、ジメチルアミンゼラン3tを加え溶解した
。この溶液に、ジエチルエーテルに塩酸ガスを加え0.
5Nとした溶液10++tA!を攪拌下部下し、反応液
を200dの飽和釆炭酸水素す) IJウム溶液にあけ
て反応を停止させた後、クロロホルム200dで抽出し
た。飽和食塩水で2回洗浄後溶媒を留去し、0.INナ
トリウムメチラートを含むメタノール溶液500dを加
え25℃で4時間攪拌後酢酸を加えて中和した。Example 1. p-Nitrophenyl 0-(6-0-benzyl)-α-D-glucopyrine-(1→4)-〇-α-D-glucopyranosyl-(1→4)-〇-α-D
-Glucopyranosyl(1→4)-〇-α-D-Glucopyranosyl(1→4)-α--D-Glucopyranosyl P
Synthesis of p-nitrophenyl-α-D-maltopentaoside 32 (hereinafter abbreviated as BG5P)
After dissolving in DMF 50 d, 15 m of penzaldehyr dimethyl acetal and 14 m of p-toluenesulfonic acid (anhydride) were added, and the mixture was stirred and reacted at 50°C for 3 hours. After the reaction, 100 mA' of pyridine was added, and 60 mA' of penzoyl chloride was added dropwise under water cooling.
The reaction was stopped by pouring into 0.00 trtl of saturated sodium bicarbonate solution. After extraction with 200 d of chloroform and washing twice with saturated brine, the solvent was distilled off. Transfer the resulting syrup to a 114-necked kolben and add THF 250 tn.
After dissolving in 1 liter of water, 3 t of dimethylamine gellan was added and dissolved. To this solution, add hydrochloric acid gas to diethyl ether.
5N solution 10++tA! The reaction solution was poured into 200 d of saturated hydrogen carbonate solution to stop the reaction, and then extracted with 200 d of chloroform. After washing twice with saturated saline, the solvent was distilled off to give a 0. After adding 500 d of a methanol solution containing IN sodium methylate and stirring at 25°C for 4 hours, acetic acid was added to neutralize.
溶媒留去後50mM酢酸溶液20−を加え、50mM酢
酸で平衡化したバイオゲルP −2(Bio−Rad
社、2crnφx150m)カラムにチャージしてBG
5Pの両分を集め凍結乾燥を行った。After evaporation of the solvent, 50mM acetic acid solution 20- was added and the biogel P-2 equilibrated with 50mM acetic acid (Bio-Rad
Co., Ltd., 2 crnφ x 150 m) column and charge it with BG.
Both parts of 5P were collected and freeze-dried.
収量 450■。Yield: 450■.
IRチャート:第1図の通り。IR chart: As shown in Figure 1.
’H−NMR:第2図の通り。'H-NMR: As shown in Figure 2.
HPLC:含量95%〔カラム:充填剤=シリカゲ#
Z−ODS 、 5C18(和光純薬工業(株)商品名
、4×150m)、溶出液二〇、1%酢酸を含むアセト
ニトリル水溶液の10チ〜80%のグラジェント。HPLC: Content 95% [Column: Filling material = Silicage #
Z-ODS, 5C18 (Wako Pure Chemical Industries, Ltd. trade name, 4 x 150 m), eluent 20, a 10-80% gradient of acetonitrile aqueous solution containing 1% acetic acid.
305 nmで測定。〕。Measured at 305 nm. ].
GCm成分板: /’ルコース/6−0−ベンジルーグ
ルコース=3.8:1゜
実施例2. p−ニトロフェニル O−(6−0−ベ
ンジル)−α−D−グルコピラ、ノシルー(1→4)−
〇−α−D−グルコピラノシルー(1→4)−〇−α−
D−グルコピラノシルー(1→4)−〇−α−D−グル
コピラノシルー(1→4)−〇−α−D−グルコピラノ
シルー(1→4)−α−D−グルコピラノシP(以下、
BG6Pと略す。)の合成
p−ニトロフェニル α−D−マルトヘキサオシド3f
をDMF 50 atに溶解後、ペンズアルデヒY−)
lチルアセタール15fi/、p−)ルエンスルホン酸
(無水)1tを加え、50℃で3時間攪拌反応させた。GCm component plate: /'lucose/6-0-benzyluglucose = 3.8:1° Example 2. p-Nitrophenyl O-(6-0-benzyl)-α-D-glucopyra, nosyru(1→4)-
〇-α-D-glucopyranosyl (1→4)-〇-α-
D-glucopyranosyl (1→4)-〇-α-D-glucopyranosyl (1→4)-〇-α-D-glucopyranosyl (1→4)-α-D-glucopyranosyl P (below,
It is abbreviated as BG6P. ) Synthesis of p-nitrophenyl α-D-maltohexaoside 3f
After dissolving in DMF 50 at, penzaldehy Y-)
1 t of l-tylacetal, 1 t of p-)luenesulfonic acid (anhydride) was added, and the mixture was stirred and reacted at 50°C for 3 hours.
反応後ピリジン100mA’を加え水冷下ベンゾイルク
ロリド80m1を滴下して反応させ、反応液を300t
lの飽和垂炭酸水素ナトリウム溶液にあけて反応を停止
させた。クロロホルム200mA’で抽出し、飽和食塩
水で2回洗浄後溶媒を留去した。得られたシロップを1
14頚コルベンに移し、 THF 250rrtlに溶
解後、ジメチルアミンゼラン3fを加え溶解した。この
溶液に、ジエチルエーテルに塩酸ガスを吹き込み0.5
Nとした溶液1゜rugを攪拌下滴下し、反応液を3
00m7?の飽和重炭酸水素ナトリウム溶液にあけて反
応を停止させた後、クロロホルム200 mlで抽出し
た。飽和食塩水で2回洗浄後溶媒を留去し、0.1Nす
) IJウムメチラートを含むメタノール溶液500d
を加え、25℃で4時間攪拌後酢酸を加えて中和した。After the reaction, 100 mA' of pyridine was added and 80 ml of benzoyl chloride was added dropwise under water cooling to react.
The reaction was stopped by pouring into 1 liter of saturated sodium bicarbonate solution. The mixture was extracted with 200 mA' of chloroform, washed twice with saturated brine, and then the solvent was distilled off. 1 of the resulting syrup
The mixture was transferred to a No. 14-necked container, dissolved in 250 rrtl of THF, and then 3 f of dimethylamine gellan was added and dissolved. Hydrochloric acid gas was bubbled into diethyl ether into this solution and 0.5
1゜rug of N solution was added dropwise under stirring, and the reaction solution was diluted with 3.
00m7? The reaction was stopped by pouring into saturated sodium bicarbonate solution, and then extracted with 200 ml of chloroform. After washing twice with saturated saline, the solvent was distilled off to 0.1N). 500 d of methanol solution containing IJ methylate.
After stirring at 25° C. for 4 hours, acetic acid was added to neutralize the mixture.
溶媒留去後、50mM酢酸溶液20mA’を加え、50
mM酢酸で平衡化したバイオゲルP −2(Bio−R
ad社、2crnφX150I:rIK)カラムにチャ
ージしてBG6Pの両分を集め凍結乾燥を行った。After evaporating the solvent, add 20mA' of 50mM acetic acid solution and
Biogel P-2 (Bio-R
ad Co., 2crnφX150I:rIK) column was charged and both portions of BG6P were collected and freeze-dried.
収量 500■。Yield: 500■.
HPLC:含量 94チ(測定条件は実施例1と同じ。HPLC: Content: 94 h (measurement conditions are the same as in Example 1).
)。).
GC組成分析:クルコース/6−0−ベンジル−グルコ
ース=4.9:1゜
実施例3. 9−二トロフェニル 0−(6−0−メチ
ル)−α−D−グルコピラノシル=(1→4)−〇−α
−D−グルコピラノシルー(1→4)−〇−α−D−グ
ルコピラノシルー(1→4)−〇−α−D−グルコピラ
ノシルー(1→4)−α−D−グルコピラノシド(以下
、M05Pと略す。)の合成
p−ニトロフェニル α−D−マルトペンタオシド5f
をDMF 40 rttlに溶解後、メチラール50r
at、p−)ルエンスルホン酸(無水)IIJD、t、
50℃で3時間攪拌反応させた。反応液を真空濃縮後、
ピリノン300m/、無水酢酸100−を加え、室温で
12時間反応させた後、反応液に飽和4炭酸水素す)
IJウム溶液500 rnlを加えて反応を停止させた
。クロロホルム100mJを加工て抽出し、飽和食塩水
で2回洗浄後溶媒を留去した。GC composition analysis: Cucrose/6-0-benzyl-glucose = 4.9:1° Example 3. 9-nitrophenyl 0-(6-0-methyl)-α-D-glucopyranosyl = (1→4)-〇-α
-D-glucopyranosyl (1 → 4) -〇-α-D-glucopyranosyl (1 → 4) -〇-α-D-glucopyranosyl (1 → 4) -α-D-glucopyranoside Synthesis of p-nitrophenyl α-D-maltopentaoside 5f (hereinafter abbreviated as M05P)
After dissolving in DMF 40 rttl, methylal 50r
at, p-) luenesulfonic acid (anhydride) IIJD, t,
The reaction was stirred at 50° C. for 3 hours. After concentrating the reaction solution in vacuo,
After adding 300 m of pyrinone and 100 m of acetic anhydride and reacting at room temperature for 12 hours, add saturated 4-hydrogen carbonate to the reaction solution.
The reaction was stopped by adding 500 rnl of IJum solution. The extract was extracted with 100 mJ of chloroform, washed twice with saturated brine, and then the solvent was distilled off.
得られたシロップを114頚コルベンニ移シ、THF2
50 tttlに溶解後、ピリジンゼラン41を加え溶
解した。この溶液に、0.5Mp−トルエンスルホン酸
のTHF溶液10−を攪拌下滴下し、反応液を200r
ILlの飽和炭酸水素ナトリウム溶液にあけて反応を停
止させた後、クロロホルム200dで抽出した。飽和食
塩水で2回洗浄後溶媒を留去し、これに、0.INナト
リウムメチラートを含むメタノール溶液を700t/加
え、25℃で4時間反応後酢酸を加えて中和した。溶媒
留去後、50:酢酸で平衡化したバイオゲルP −2(
Bio−Rad社、2tMφX150cm)カラムにチ
ャージしてMG5Pの画分を集め凍結乾燥を行った。Transfer the resulting syrup to 114 ml of THF.
After dissolving in 50 tttl, pyridine gellan 41 was added and dissolved. To this solution, a solution of 0.5M p-toluenesulfonic acid in THF (10) was added dropwise with stirring, and the reaction solution was stirred at 200 rpm.
After pouring into a saturated sodium bicarbonate solution of IL1 to stop the reaction, the mixture was extracted with 200 d of chloroform. After washing twice with saturated brine, the solvent was distilled off, and 0. 700 t/methanol solution containing IN sodium methylate was added, and after reacting at 25°C for 4 hours, acetic acid was added to neutralize. After evaporation of the solvent, biogel P-2 equilibrated with 50:acetic acid (
The MG5P fraction was collected by charging a column (Bio-Rad, 2tMφX150cm) and freeze-dried.
収量 730■。Yield: 730■.
HPLC:含量 93チ(測定条件は実施例1と同じ。HPLC: Content: 93 h (measurement conditions are the same as in Example 1).
)。).
本発明は、α−アミラーゼ活性測定用基質として、或は
ヒトα−アミラーゼの各アイソデイム活性の分別測定用
基質として有用な非還元末端修飾オリゴサッカライP誘
導体の新規で且つ効果的な製造法を提供するものであり
、本発明の方法によれば非還元末端修飾オリゴサツカラ
イド誘導体が簡単な反応操作で、収率よく得ることがで
きるので、これらを基質として用いるα−アミラーゼ活
性測定法或は同アイソザイムの分別測定法の実用化(企
業化)に寄与するところ甚だ大なる点に顕著な効果を奏
するものである。The present invention provides a novel and effective method for producing non-reducing end-modified oligosaccharide P derivatives that are useful as substrates for measuring α-amylase activity or as substrates for differentially measuring the activities of each isodime of human α-amylase. According to the method of the present invention, non-reducing end-modified oligosaccharide derivatives can be obtained in high yield with simple reaction operations, and therefore, α-amylase activity assay methods using these as substrates or This has had a significant effect in contributing to the practical application (commercialization) of the method for separately measuring the isozyme.
第1図は実施例1で得られた非還元末端修飾オリゴサッ
カライP誘導体のIRチャートを示し、第2図は実施例
1で得られた非還元末端修飾オリゴサッカライr誘導体
の懇チャートを示す。Figure 1 shows the IR chart of the non-reducing end-modified oligosaccharide P derivative obtained in Example 1, and Figure 2 shows the IR chart of the non-reducing end-modified oligosaccharide r derivative obtained in Example 1. show.
Claims (2)
ていても良いフェノキシ基、置換基を有していても良い
ナフトキシ基、置換基を有していても良いウンベリフェ
リル基、置換基を有していても良いインドキシル基又は
フルクトース残基で置換された修飾オリゴサッカライド
の非還元末端グルコースにアルデヒド類、ケトン類、ア
セタール類又はケタール類を反応させて4,6−O−環
状アセタール又は4,6−O−環状ケタールとし、次い
でこれを還元することを特徴とする、一般式〔 I 〕▲
数式、化学式、表等があります▼〔 I 〕 〔式中、R^1はベンジル基、置換ベンジル基(置換基
は、低級アルキル基、低級アルコキシ基、アルキル置換
アミノ基、カルボキシル基、ニトロ基又はハロゲン原子
を示す。)、2−、3−又は4−ピリジルメチル基、炭
素数1〜6の直鎖状、分枝状又は環状のアルキル基又は
炭素数1〜6のアルケニル基を表わし、R^2は ▲数式、化学式、表等があります▼、▲数式、化学式、
表等があります▼、▲数式、化学式、表等があります▼ (但し、R^3〜R^6は水素原子、低級アルキル基、
低級アルコキシ基、ニトロ基、カルボキシル基、スルホ
ン酸基又はハロゲン原子を表わし、夫々同じであっても
異なっていても良く、また、R^3とR^5又はR^4
とR^6とが結合して芳香環を形成していても良い。R
^7は水素原子、低級アルコキシ基、ハロゲン原子又は
ニトロ基を表わす。また、R^8は水素原子、メチル基
又はトリフルオロメチル基を表わし、R^9は水素原子
又はハロゲン原子を表わす。)又は▲数式、化学式、表
等があります▼ を表わし、nは2〜5の整数を表わす。〕 で示されるオリゴサッカライド誘導体の製造法。(1) A phenoxy group which may have a substituent on the 1-position hydroxyl group of the reducing terminal glucose, a naphthoxy group which may have a substituent, an umbelliferyl group which may have a substituent, a substituent The non-reducing terminal glucose of a modified oligosaccharide substituted with an indoxyl group or a fructose residue, which may have an optional group, is reacted with an aldehyde, a ketone, an acetal, or a ketal to form a 4,6-O-cyclic The general formula [I]▲ is characterized by forming an acetal or a 4,6-O-cyclic ketal and then reducing this.
There are mathematical formulas, chemical formulas, tables, etc. represents a halogen atom), a 2-, 3- or 4-pyridylmethyl group, a linear, branched or cyclic alkyl group having 1 to 6 carbon atoms, or an alkenyl group having 1 to 6 carbon atoms, R ^2 has ▲mathematical formulas, chemical formulas, tables, etc.▼, ▲mathematical formulas, chemical formulas,
There are tables, etc. ▼, ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (However, R^3 to R^6 are hydrogen atoms, lower alkyl groups,
Represents a lower alkoxy group, nitro group, carboxyl group, sulfonic acid group or halogen atom, which may be the same or different, and R^3 and R^5 or R^4
and R^6 may be combined to form an aromatic ring. R
^7 represents a hydrogen atom, a lower alkoxy group, a halogen atom or a nitro group. Further, R^8 represents a hydrogen atom, a methyl group or a trifluoromethyl group, and R^9 represents a hydrogen atom or a halogen atom. ) or ▲There are mathematical formulas, chemical formulas, tables, etc.▼, and n represents an integer from 2 to 5. ] A method for producing an oligosaccharide derivative represented by.
ルコースにアルデヒド類、ケトン類、アセタール類又は
ケタール類を反応させて4,6−O−環状アセタール又
は4,6−O−環状ケタールとした後、アシル化により
他の水酸基を修飾し、然る後これを還元する特許請求の
範囲第1項記載の製造法。(2) After reacting the non-reducing end glucose of the reducing end-modified oligosaccharide with aldehydes, ketones, acetals, or ketals to form a 4,6-O-cyclic acetal or a 4,6-O-cyclic ketal, 2. The production method according to claim 1, wherein other hydroxyl groups are modified by acylation and then reduced.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63010497A JPH0686474B2 (en) | 1987-01-26 | 1988-01-20 | A novel method for producing non-reducing end-modified oligosaccharide derivatives |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1577687 | 1987-01-26 | ||
JP62-15776 | 1987-01-26 | ||
JP63010497A JPH0686474B2 (en) | 1987-01-26 | 1988-01-20 | A novel method for producing non-reducing end-modified oligosaccharide derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63301892A true JPS63301892A (en) | 1988-12-08 |
JPH0686474B2 JPH0686474B2 (en) | 1994-11-02 |
Family
ID=26345781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63010497A Expired - Lifetime JPH0686474B2 (en) | 1987-01-26 | 1988-01-20 | A novel method for producing non-reducing end-modified oligosaccharide derivatives |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0686474B2 (en) |
-
1988
- 1988-01-20 JP JP63010497A patent/JPH0686474B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH0686474B2 (en) | 1994-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0270946B1 (en) | Chromogenic acridinone enzyme substrates | |
JPH0222288A (en) | Oligoglucoside derivative | |
JPS6183195A (en) | Novel oligosaccharide derivative and determination of alpha-amylase using same as a substrate | |
US4932871A (en) | Rapid method for preparing chromogenic alpha-amylase substrate compounds at high preparative yields | |
EP0530850B1 (en) | Process for producing a modified oligosaccharide | |
JPH0631293B2 (en) | Malto-oligosaccharide derivative and reagent for measuring amylase activity | |
US5319078A (en) | α-amylase assay using modified oligosaccharide and process for producing said modified oligosaccharide | |
JPS63301892A (en) | Novel production of nonreducing end modified oligosaccharide derivative | |
JP2770891B2 (en) | Maltooligoside derivative, reagent for measuring α-amylase activity using the same as active ingredient, and method for measuring α-amylase activity using the same | |
JPH0655753B2 (en) | Novel oligoglucoside derivative, measuring method and measuring reagent for α-amylase | |
US5011923A (en) | Polyacetyl oligosaccharide derivatives | |
JPH03264596A (en) | Galactosyl-malto oligosaccharide derivative, preparation thereof and method for measuring activity of alpha-amylase | |
EP0459536A1 (en) | Chromogenic acridinone enzyme substrates | |
US5300634A (en) | Process for producing maltooligosaccharide derivative | |
JPH0676430B2 (en) | New method for measuring α-amylase activity | |
JPS6087297A (en) | Cyclic acetal derivative of alpha,beta-nucleus-substituted phenylmaltooligoside, its preparation, and measurement of amylase activity using substrate thereof | |
JP3029925B2 (en) | Maltooligosaccharide derivatives and their production | |
JP3070709B2 (en) | Method for producing maltooligosaccharide derivatives | |
JPH0650996B2 (en) | Substrate for measuring α-amylase activity and measuring method | |
JPH04229196A (en) | Fractional determination of alpha-amylase isozyme activity | |
JPH0630602B2 (en) | A novel method for producing non-reducing end-modified oligosaccharide derivatives | |
JPH05161498A (en) | Production of non-reducing end-group-modified phenylated maltotetraose derivative | |
JPH1017590A (en) | Modified alpha-maltooligoside derivative, reagent for measuring alpha-amylase activity comprising the same as active component, measurement of alpha-amylase activity using the same and production of modified alpha-maltooligoide derivative | |
JPH07107987A (en) | Production of non-reducing terminal-modified oligomaltose derivative | |
JPH0656869A (en) | 6-alkoxymethoxymaltooligoside derivative, alpha-amylase activity determination reagent containing the derivative as active component and determination of alpha-amylase activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081102 Year of fee payment: 14 |